DTA-002 📄 Overview A SaMD that delivers personalized therapeutic interventions for chronic conditions (e.g., pain management, mental health, adherence support) by dynamically adapting content, intensity, and feedback based on real-time patient biometric data (from integrated wearables), self-reported symptoms, and behavioral engagement patterns. Key technologies: 👤 Target users: 👍 Benefits Enhanced patient adherence and motivation • Improved clinical outcomes through personalized therapy • Reduced burden on healthcare professionals • Scalable access to evidence-based interventions • Objective measurement of patient progress Use bullets or new lines. 👎 Challenges Achieving sustained patient engagement and retention • Clinical validation through randomized controlled trials (RCTs) • Integration into existing clinical workflows and EMRs • Payer reimbursement pathways and value demonstration • Data privacy and security for highly personal health information 📋 Regulatory & Validation Likely Class II or III SaMD, similar to a traditional medical device • Requires rigorous clinical trials to prove safety and efficacy for specific therapeutic claims • Compliance with ISO 13485 and quality management system requirements • Cybersecurity assessment due to sensitive data and connectivity